SQI Diagnostics IncTSXV:SQD.H
- LAST PRICE0.0150
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0150
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SQI Diagnostics Inc | 6.1M | -0.3x | --- |
Hydreight Technologies Inc | 18.5M | -10.5x | --- |
Filament Health Corp | 7.9M | -1.4x | --- |
Scryb Inc | 6.4M | -0.4x | --- |
CardioComm Solutions Inc | 3.9M | -21.5x | --- |
ZoomMed Inc | 2.1M | 1.4x | --- |
Company Information
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.
Contact Information
- Headquarters
- 36 Meteor DrETOBICOKE, ON, Canada M9W 1A4
- Phone
- 416-674-9500
- Fax
- 416-674-9500
Executives
- Chief Financial Officer
- Morlan Reddock
- Director
- David Markowski
- Independent Director
- Gerald Connor
- Independent Director
- Claude Ricks
- Independent Director
- Eric Zwisler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.1M |
|---|---|
Revenue (TTM) | $3.0M |
Shares Outstanding | 407.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.47 |
EPS | $-0.05 |
Book Value | $-0.02 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -629.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
